Trinity Biotech Announces Reverse ADS Split to Regain Compliance
Trinity Biotech Plc. (NASDAQ: TRIB), a developer and marketer of diagnostic systems, has announced a significant change in the ratio of its American depositary shares (ADSs) to Class A ordinary shares. Effective from February 21, 2024, the current ratio of one ADS representing four Class A ordinary shares will be adjusted to one ADS representing twenty Class A ordinary shares.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
